tirzepatide shortage news october 2025 National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and Tirzepatide (Zepbound®) Removed From FDA's

Overall, the data revealed that both semaglutide and tirzepatide are associated with significant reductions in the composite risk of all-cause mortality and hospitalization due to heart failure

A board-certified physician reviews your health history, goals, and prior treatment response before deciding whether a dual-pathway option is appropriate

Key ones include: Magnesium citrate (200-400 mg daily): Helps prevent constipation, supports sleep quality, and reduces muscle cramps B12 or methylcobalamin: GLP-1 agonists can reduce B12 absorption over time, and some compounded formulations include B12 in the compound for this reason Electrolytes: Sodium, potassium, and magnesium supplementation helps offset the dehydration risk from reduced food intake Protein powder: A practical way to maintain protein targets when appetite makes eating full meals difficult Some compounded formulations include additional ingredients like glycine , niacinamide , or glycine plus B12 combinations

Warning signs include dark urine, dizziness , a dry mouth, reduced urination, and feeling unusually weak

Tirzepatide is used in controlled laboratory settings to help researchers evaluate targeted biological pathways

Phase 3 trials are ongoing, with potential approval estimated for mid-to-late 2026 or early 2027